Innovation Pharmaceuticals Inc (IPIX)

[Ernesto]

First, "Ovarian cancer is the seventh most common cancer in women worldwide (18 most common cancer overall), with 239,000 new cases diagnosed in 2012." Second, The orphan drug designation is for hard to treat cases, mostly defined as platinum resistant.

Good to know. Never too much frosting on the cake.

However, you are correct that 111 billion is probably total global ca, though that seems low. Certainly, as pharma increase efficacy and decrease pain for treatments the total market is likely to increase several fold from whatever it currently is.

I don't know the accuracy of the numbers in either article only that the one incorrectly quotes the other.